A detailed history of Legal & General Group PLC transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Legal & General Group PLC holds 4,977 shares of ENOB stock, worth $22,894. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,977
Previous 4,977 -0.0%
Holding current value
$22,894
Previous $22,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
N/A
4,977 New
4,977 $22,000
Q2 2022

Aug 22, 2022

BUY
$1.93 - $8.73 $3,190 - $14,430
1,653 New
1,653 $3,000
Q2 2021

Aug 12, 2021

SELL
$2.94 - $6.79 $3,222 - $7,441
-1,096 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$3.42 - $4.55 $4,069 - $5,414
-1,190 Reduced 52.06%
1,096 $4,000
Q4 2019

Feb 13, 2020

BUY
$3.48 - $6.75 $7,955 - $15,430
2,286 New
2,286 $11,000

Others Institutions Holding ENOB

About Enochian Biosciences Inc


  • Ticker ENOB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,950,000
  • Market Cap $244M
  • Description
  • Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...
More about ENOB
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.